Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07WQV
|
||||
Former ID |
DIB018785
|
||||
Drug Name |
AH23848
|
||||
Synonyms |
(-)AH23848; AH23848; (-)-AH23848; AH 23848; AH-23848
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C29H35NO5
|
||||
InChI |
InChI=1S/C29H35NO5/c31-26-20-27(35-21-22-12-14-24(15-13-22)23-8-4-3-5-9-23)25(10-6-1-2-7-11-28(32)33)29(26)30-16-18-34-19-17-30/h1-5,8-9,12-15,25,27,29H,6-7,10-11,16-21H2,(H,32,33)/b2-1-/t25-,27-,29+/m0/s1
|
||||
InChIKey |
IOFUFYLETVNNRF-OSAZKUMMSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Thromboxane A2 receptor | Target Info | Antagonist | [2] | |
Prostaglandin E2 receptor, EP4 subtype | Target Info | Antagonist | [3] | ||
KEGG Pathway | Calcium signaling pathway | ||||
Neuroactive ligand-receptor interaction | |||||
Platelet activationhsa04080:Neuroactive ligand-receptor interaction | |||||
Inflammatory mediator regulation of TRP channels | |||||
Renin secretion | |||||
Pathways in cancer | |||||
NetPath Pathway | FSH Signaling Pathway | ||||
IL2 Signaling Pathway | |||||
IL4 Signaling Pathway | |||||
TGF_beta_Receptor Signaling Pathway | |||||
Reactome | Prostanoid ligand receptors | ||||
G alpha (q) signalling events | |||||
G alpha (12/13) signalling events | |||||
Thromboxane signalling through TP receptorR-HSA-391908:Prostanoid ligand receptors | |||||
G alpha (s) signalling events | |||||
WikiPathways | GPCRs, Class A Rhodopsin-like | ||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
Small Ligand GPCRs | |||||
Signal amplification | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP98:Prostaglandin Synthesis and Regulation | |||||
Vitamin D Receptor Pathway | |||||
GPCR downstream signaling | |||||
References | |||||
REF 1 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1949). | ||||
REF 2 | The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim Biophys Acta. 2000 Jan 17;1483(2):285-93. | ||||
REF 3 | Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes. Eur J Pharmacol. 1997 Dec 11;340(2-3):227-41. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.